MYNN
Myoneurin
Also known as: MYNN_HUMAN, SBBIZ1, ZBTB31, ZNF902
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPC7
- Gene
- MYNN
- Ensembl
- ENSG00000085274
- Chromosome
- 3
- Canonical length
- 610 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the BTB/POZ and zinc finger domain-containing protein family that are involved in the control of gene expression. Alternative splicing results in multiple transcript variants and a pseudogene has been identified on chromosome 14. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
610 residues, UniProt reviewed canonical sequence.
>Q9NPC7|MYNN
1 MQYSHHCEHL LERLNKQREA GFLCDCTIVI GEFQFKAHRN VLASFSEYFG AIYRSTSENN
61 VFLDQSQVKA DGFQKLLEFI YTGTLNLDSW NVKEIHQAAD YLKVEEVVTK CKIKMEDFAF
121 IANPSSTEIS SITGNIELNQ QTCLLTLRDY NNREKSEVST DLIQANPKQG ALAKKSSQTK
181 KKKKAFNSPK TGQNKTVQYP SDILENASVE LFLDANKLPT PVVEQVAQIN DNSELELTSV
241 VENTFPAQDI VHTVTVKRKR GKSQPNCALK EHSMSNIASV KSPYEAENSG EELDQRYSKA
301 KPMCNTCGKV FSEASSLRRH MRIHKGVKPY VCHLCGKAFT QCNQLKTHVR THTGEKPYKC
361 ELCDKGFAQK CQLVFHSRMH HGEEKPYKCD VCNLQFATSS NLKIHARKHS GEKPYVCDRC
421 GQRFAQASTL TYHVRRHTGE KPYVCDTCGK AFAVSSSLIT HSRKHTGEKP YICGICGKSF
481 ISSGELNKHF RSHTGERPFI CELCGNSYTD IKNLKKHKTK VHSGADKTLD SSAEDHTLSE
541 QDSIQKSPLS ETMDVKPSDM TLPLALPLGT EDHHMLLPVT DTQSPTSDTL LRSTVNGYSE
601 PQLIFLQQLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYNN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- retina: 14 nTPM
- bone marrow: 14 nTPM
- tongue: 10 nTPM
- endometrium: 9.6 nTPM
- testis: 9.2 nTPM
- tonsil: 9.2 nTPM
Single-cell type
- late primary spermatocytes: 62 nCPM
- rod photoreceptor cells: 62 nCPM
- neutrophils: 55 nCPM
- early spermatids: 47 nCPM
- basal keratinocytes: 46 nCPM
- suprabasal keratinocytes: 42 nCPM
Immune cell
- basophil: 22 nTPM
- eosinophil: 11 nTPM
- NK-cell: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- MAIT T-cell: 10 nTPM
- T-reg: 9.1 nTPM
Brain region
- cerebellum: 16 nTPM
- white matter: 12 nTPM
- cerebral cortex: 11 nTPM
- choroid plexus: 11 nTPM
- basal ganglia: 9.8 nTPM
- midbrain: 8.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYNN as an antibody target. Whether an autoantibody or antibody against MYNN could matter depends on whether native MYNN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYNN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYNN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...